Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GE HealthCare Technologies (GEHC) Invested Capital (2022 - 2025)

Historic Invested Capital for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $20.4 billion.

  • GE HealthCare Technologies' Invested Capital rose 1710.02% to $20.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.4 billion, marking a year-over-year increase of 1710.02%. This contributed to the annual value of $20.4 billion for FY2025, which is 1710.02% up from last year.
  • GE HealthCare Technologies' Invested Capital amounted to $20.4 billion in Q4 2025, which was up 1710.02% from $20.3 billion recorded in Q3 2025.
  • GE HealthCare Technologies' Invested Capital's 5-year high stood at $20.4 billion during Q4 2025, with a 5-year trough of $6.9 billion in Q1 2023.
  • Its 4-year average for Invested Capital is $15.9 billion, with a median of $17.1 billion in 2022.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 5848.72% in 2023, then soared by 16083.37% in 2024.
  • Over the past 4 years, GE HealthCare Technologies' Invested Capital (Quarter) stood at $17.6 billion in 2022, then dropped by 5.81% to $16.6 billion in 2023, then rose by 4.99% to $17.4 billion in 2024, then grew by 17.1% to $20.4 billion in 2025.
  • Its Invested Capital stands at $20.4 billion for Q4 2025, versus $20.3 billion for Q3 2025 and $20.0 billion for Q2 2025.